1,5 Anhydroglucitol in gestational diabetes mellitus

Objective: 1,5 Anhydroglucitol (1,5 AG) is reported to be a more sensitive marker of glucose variability and shortterm glycemic control (1-2 weeks) in patients with typel and type 2 diabetes. However, the role of 1,5 AG in gestational diabetes mellitus (GDM) is not clear. We estimated the serum levels of 1,5 AG in pregnant women with and without GDM. Methods: We recruited 220 pregnant women, 145 without and 75 with GDM visiting antenatal clinics in Tamil Nadu in South India. Oral glucose tolerance tests (OGTTs) were carried out using 82.5 g oral glucose (equivalent to 75 g of anhydrous glucose) and GDM was diagnosed based on the International Association of Diabetes and Pregnancy Study Group criteria. Serum 1,5 AG levels were measured using an enzymatic, colorimetric assay kit (Glycomark (R), New York, NY). Receiver operating characteristic (ROC) curves were used to identify 1,5 AG cut-off points to identify GDM. Results: The mean levels of the 1,5 AG were significantly lower in women with GDM (11.8 +/- 5.7 mu g/mL, p < 0.001) compared to women without GDM (16.2 +/- 62 mu g/mL). In multiple logistic regression analysis, 1.5 AG showed a significant association with GDM (odds ratio [OR]: 0.876, 95% confidence interval [CI]: 0.812-0.944, p < 0.001) after adjusting for potential confounders. 1,5 AG had a C statistic of 0.693 compared to Fructosamine (0.671) and HbA1c (0.581) for identifying GDM. A 1,5 AG cut-off of 13.21 mu g/mL had a C statistic of 0.6936 (95% Cl: 0.6107-0.7583, p < 0.001), sensitivity of 67.6%, and specificity of 653% to identify GDM. Conclusion: 1,5AG levels are lower in pregnant women with GDM compared to individuals without GDM. (C) 2018 The Authors.